Enstar Group Limited Reports 2014 Year End Results

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Enstar Group Limited Reports 2014 Year End Results

HAMILTON, Bermuda, March 2, 2015 (GLOBE NEWSWIRE) -- Enstar Group Limited (Nasdaq: ESGR ) filed its annual report on Form 10-K with the SEC earlier today, reporting its earnings and financial position for the year ended December 31, 2014.

Enstar reported consolidated net earnings of $213.7 million (or $11.44 per fully diluted share) for the year ended December 31, 2014 compared to $208.6 million (or $12.49 per fully diluted share) for the year ended December 31, 2013.

Enstar's shareholders' equity at December 31, 2014 amounted to $2,304.9 million (or $119.22 per fully diluted share), which was up from $1,755.5 million (or $105.20 per fully diluted share) at December 31, 2013. The Form 10-K, which is available on Enstar's website, www.enstargroup.com , contains a more detailed description of Enstar's business and financial results.

Enstar also announced today that it has amended its revolving credit facility to increase borrowing capacity from $500 million to $665 million. The amended facility adds Lloyd's Bank plc to the existing lending syndicate of National Australia Bank Limited, Barclays Bank PLC and Royal Bank of Canada.

In addition, Enstar appointed Rick Becker to its Board of Directors on February 25, 2015. Mr. Becker, 68, is the Chairman of Clarity Group, Inc., a U.S. national healthcare professional liability and risk management organization which he co-founded over 13 years ago. He has 35 years of experience within the insurance and healthcare industries.

This press release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include statements regarding the intent, belief or current expectations of Enstar and its management team. Investors are cautioned that any such forward-looking statements speak only as of the date they are made, are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors. Important risk factors regarding Enstar may be found under the heading "Risk Factors" in Enstar's Form 10-K for the year ended December 31, 2014, and are incorporated herein by reference. Furthermore, Enstar undertakes no obligation to update any written or oral forward-looking statements or publicly announce any updates or revisions to any of the forward-looking statements contained herein, to reflect any change in its expectations with regard thereto or any change in events, conditions, circumstances or assumptions underlying such statements, except as required by law.

Richard J. Harris (441) 292-3645

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 4

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 4

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 7

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 6

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading

Top 5 Most Recently Viewed Articles

Currax Reports Strong Performance Driven by Global Demand Surge

Updated Category News Views 669

Currax Pharmaceuticals Achieves Remarkable Growth in 2024 Currax Pharmaceuticals LLC, a leading specialty pharmaceutical company, has recently announced outstanding financial and operational performance for the year. Fueled by a significant increase in the global demand for its flagship products CONTRAVE and MYSIMBA, the company has reported over 50% growth in revenue for...

Continue Reading
Exploring Amazon's Upcoming Financial Results and Future Prospects

Updated Category News Views 209

Anticipating Amazon's Q3 Earnings Report Amazon.com Inc (NASDAQ: AMZN) is on the brink of revealing its third-quarter financial performance, a moment that could reflect the company's resilience amidst recent challenges. With a backdrop dominated by headlines of job cuts and an AWS outage, analysts are keenly observing what the earnings report will unveil. This article...

Continue Reading
Melco Resorts Finance Launches $500 Million Senior Notes Offering

Updated Category News Views 140

Melco Resorts Finance Announces Senior Notes Offering Melco Resorts Finance Limited has taken an important step with its recent announcement regarding a new senior notes offering. This offering, valued at a substantial US$500 million, aims to bolster the financial stability and operational capabilities of Melco Resorts Finance, a key subsidiary of Melco Resorts &...

Continue Reading
Bloom Energy's Options Surge: Decoding Market Movements

Updated Category News Views 203

Understanding the Buzz Around Bloom Energy Options In the world of stock trading, Bloom Energy (NYSE: BE) is currently capturing the attention of investors with its recent options trading activity. Wealthy investors are increasingly adopting a bullish stance, making this a key moment for market participants to analyze. The stark changes in option trading volumes have...

Continue Reading
Pharvaris Sets Terms for Significant Public Offering of Shares

Updated Category News Views 174

Pharvaris Announces Major Public Offering Pharvaris N.V. (NASDAQ: PHVS) has recently revealed its plans for a significant public offering aimed at raising approximately $175 million. This offering is primarily focused on the company's ordinary shares and pre-funded warrants. Details of the Offering The offering comprises a total of 8,250,000 ordinary shares priced at...

Continue Reading